Translating Gene Transfer: A Stalled Effort

Clinical and Translational Science

Volumn 4, Issue 4, 2011, Pages 279-281

  Greenberg, Alexandra J ^a   Mccormick, Jennifer ^b   Tapia, Carmen J ^a   Windebank, Anthony J ^a  

^a Mayo Clinic College of Medicine   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Commentary; Gene therapy; Viruses

Indexed keywords

ANTIRETROVIRUS AGENT; CYTOKINE RECEPTOR; GAMMA C CHAIN CYTOKINE RECEPTOR; RECOMBINANT DNA; UNCLASSIFIED DRUG; VIRUS VECTOR;

CELL MANIPULATION; CLINICAL TRIAL (TOPIC); DRUG SAFETY; GENE TRANSFER; GENETIC RECOMBINATION; GERM LINE GENE THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKEMIA; META ANALYSIS; MURINE LEUKEMIA VIRUS; NONHUMAN; NOTE; ORNITHINE TRANSCARBAMYLASE DEFICIENCY; PRIORITY JOURNAL; RECOMBINANT DNA TECHNOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSLATION; SOMATIC GENE THERAPY; X LINKED SEVERE COMBINED IMMUNODEFICIENCY;

CLINICAL TRIALS AS TOPIC; GENE THERAPY; HIV INFECTIONS; HUMANS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 80052235170     PISSN: 17528054     EISSN: 17528062     Source Type: Journal    
DOI: 10.1111/j.1752-8062.2011.00297.x     Document Type: Note

References (25)

1. Smith KR. Gene therapy: theoretical and bioethical concepts. Arch Med Res. 2003; 34: 247-268.
2. Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet. 2003; 4: 346-358.
3. Friedmann T. A brief history of gene therapy. Nat Genet. 1992; 2: 93-98.
4. Avery OT, MacLeod CM, McCarty M. Studies on the chemical nature of the substance inducing transformation of pneumonococcal types: induction of transformation by a desoxyribonucleic acid fraction isolated from pneunomonococcus type III. J Exp Med. 1944; 79: 137-158.
5. Sybalska EH, Sybalski W. Genetics of human cell lines, IV. DNA-mediated heritable transformation of a biochemical trait. Proc Natn Acad Sci U.S.A. 1962; 48: 2026-2034.
6. Temin HM, Mizutani S. RNA-directed DNA polymerase in virions of Rous sarcoma virus. Nature. 1970; 226: 1211-1213.
7. Baltimore D. RNA-depedent DNA polymerase in virions of RNA tumor viruses. Nature. 1970; 226: 1209-1211.
8. Sambrook J, Westphal H, Srinivasan PR, Dulbecco R. The integrated state of viral DNA in SV40-transformed cells. Proc Natn Acad Sci U.S.A. 1968; 59: 1288-1293.
9. Hill M, Hillova J. Virus recovery in chicken cells treated with Rous sarcoma cell DNA. Nature NBiol. 1972; 237: 35-39.
10. Cohen SN, Chang AC, Boyer HW, Helling RB. Construction of biologically functional bacterial plasmids in vitro. Proc Natn Acad Sci U.S.A. 1973; 70: 3240-3244.
11. Graham FL, van der Eb AJ. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 1973; 52: 456-467.
12. Maniatis T, Kee SG, Efstratiadis A, Kafatos FC. Amplification and characterization of beta-globin gene synthesized in vitro. Cell. 1976; 8: 163-182.
13. Rogers S, Lowenthal A, Terheggen HG, Columbo JP. Induction of arginase activity with the Shope papilloma virus in tissue culture cells from an argininemic patient. J Exp Med. 1973; 137: 1091-1096.
14. Hindmarsh R, Gottweis H. Recombinant regulation: the Asilomar legacy 30 years on. Sci Cult (Lond). 2005; 14: 299-309.
15. Berg P. Reflections on Asilomar 2 at Asilomar 3. Persp in Bio and Med. 2001; 44: 183-185.
16. Weiner C. Drawing the line in genetic engineering: self-regulation and public participation. Persp. in Bio and Med. 2001; 44: 208-220.
17. Kelly EB. Gene therapy. Westport, CT Greenwood Press; 2007: 33
18. Anderson WF. Gene therapy: the best of times, the worst of times. Science. 2000; 288: 267-269.
19. Balas EA, Boren SA. Managing clinical knowledge for health care improvement. Yearb Med Inform. 2000; 65-70.
20. Lane N. Benjamin Franklin, Civic Scientist. Phys Today. 2003; 56: 41-46.
21. Wolinsky H. The pendulum swung. EMBO Reports. 2009; 10: 436-439.
22. Cavazzana-Calvo M, Hacein-Bay S, de Saint Basile G, Gross F, Yvon E, Nusbaum P, Selz F, Hue C, Certain S, Casanova JL, et al. Gene therapy of severe combined immunodeficiency (SCID)-X1 disease. Science. 2000; 288: 669-672.
23. Kohn DB, Sadelain M, Glorioso JC. Occurence of leukemia following gene therapy of X-linked SCID. Nat Rev Cancer. 2003; 3: 477-488.
24. Ledford H. Targeted gene editing enters clinic. Nature. 2011; 471: 16.
25. Gardner A. Gene therapy against HIV not a proven cure, experts say. Bloomberg Businessweek March 01. Bloomberg L.P., 2011. Available at